Stocks on watch: IPXL, UPI, SAAS

Stocks on watch: IPXL, UPI, SAASImpax Laboratories, Inc. (Public, NASDAQ:IPXL). last Market Price: 27.52, Change: +0.01, % Change: (0.04%). Shares trade in the range of 27.41 – 27.80 dollars. it has a market capitalization of 1.79B dollars and has 65.07M outstanding shares. the company has a beta of 0.56, indicating, the stock to be less volatile than the market. as per the most recent quarterly report, the net income per share (EPS) is 3.85; P/E of 7.16. it operates in Healthcare sector and belongs to Biotechnology and Drugs industry. the organization is a technology-based, specialty pharmaceutical company. the company has a 52 week high of $ 28.06 and a 52 week low of $ 7.20. Average volumes of shares traded daily are 753,445.00. Volume traded in the last session was at 580,738.00, 0.77 times the average volume. Impax Laboratories (IPXL) announced that it will collaborate with Banner Pharmacaps Inc. with respect to the supply and commercialization of two softgel capsule products. Uroplasty, Inc. (Public, NASDAQ:UPI). last Market Price: 7.01, Change: -0.54, % Change: (-7.15%). Shares trade in the range of 6.95 – 7.60 dollars. it has a market capitalization of 144.65M dollars and has 20.63M outstanding shares. the company has a beta of 1.53, indicating, the stock to be more volatile than the market. as per the most recent quarterly report, the net income per share (EPS) is -0.22. it operates in Healthcare sector and belongs to Medical Equipment and Supplies industry. the organization is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. the company has a 52 week high of $ 7.96 and a 52 week low of $ 2.85. Average volumes of shares traded daily are 106,870.00. Volume traded in the last session was at 313,067.00, 2.93 times the average volume. Uroplasty (UPI) announced that NHIC will cover posterior tibial nerve stimulation using Uroplasty’s Urgent PC Neuromodulation System for the treatment of overactive bladder and associated symptoms, effective May 22, 2011. inContact, Inc. (Public, NASDAQ:SAAS). last Market Price: 3.34, Change: -0.03, % Change: (-0.89%). Shares trade in the range of 3.34 – 3.57 dollars. it has a market capitalization of 119.31M dollars and has 35.72M outstanding shares. the company has a beta of 0.94, indicating, the stock to be less volatile than the market. as per the most recent quarterly report, the net income per share (EPS) is -0.03. it operates in Technology sector and belongs to Software and Programming industry. the organization is a provider of cloud computing (also referred to as software as a service or (SaaS)) contact center services and network connectivity. the company has a 52 week high of $ 3.75 and a 52 week low of $ 2.12. Average volumes of shares traded daily are 65,638.00. Volume traded in the last session was at 49,552.00, 0.75 times the average volume. inContact (SAAS) announced that an expanding U.S. based outsourcer has selected the inContact solution to better serve its growing energy industry clientele.

Tagged as: drugs industry, healthcare sector, laboratories inc, nasdaq, outstanding shares, upi